SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...

Guidance remains unchanged, with management projecting "over $100 million in partnership inflows by the end of 2026" and targeting a cash burn below $390 million in 2026. The company anticipates a ...

If you have credit cards that earn cash back, points or miles, you may not know how to redeem your rewards. Here's a guide on understanding rewards programs.

Semaglutide is the active ingredient in Ozempic and Wegovy. Here's what you need to know, including which variation is FDA approved for weight loss.